![Eoin McKinney](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Cargos activos de Eoin McKinney
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Predictimmune Ltd.
![]() Predictimmune Ltd. Medical SpecialtiesHealth Technology Predictimmune Ltd. develops tools for guiding treatment options in immune-mediated inflammatory diseases. It offers PredictSURE IBD is a biomarker test, combined with a sophisticated, proprietary algorithm that will tell the likely course of newly diagnosed patients’ IBD, differentiating between an aggressive or milder form of the disease. The company was founded in May 2017 and is headquartered in Cambridge, the United Kingdom. | Director Técnico/Científico/I+D | - | - |
Fundador | - | - |
Historial de carrera de Eoin McKinney
Estadísticas
Internacional
Reino Unido | 2 |
Operativa
Chief Tech/Sci/R&D Officer | 1 |
Founder | 1 |
Sectorial
Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 1 |
---|---|
Predictimmune Ltd.
![]() Predictimmune Ltd. Medical SpecialtiesHealth Technology Predictimmune Ltd. develops tools for guiding treatment options in immune-mediated inflammatory diseases. It offers PredictSURE IBD is a biomarker test, combined with a sophisticated, proprietary algorithm that will tell the likely course of newly diagnosed patients’ IBD, differentiating between an aggressive or milder form of the disease. The company was founded in May 2017 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
- Bolsa de valores
- Insiders
- Eoin McKinney
- Experiencia